New prognostic factor telomerase reverse transcriptase promotor mutation presents without MR imaging biomarkers in primary glioblastoma.
Tunc F ErsoyVera Catharina KeilDariusch R HadizadehGerrit H GielenRolf FimmersAndreas WahaBarbara HeidenreichRajiv KumarHans H SchildMatthias SimonPublished in: Neuroradiology (2017)
Imaging biomarkers for prediction of TERT mutation status remain weak and cannot be derived from the VASARI protocol. Tumor-associated seizures are less common in TERT mutated glioblastomas.